ToxStrategies to present and exibit at the Society of Toxicology’s annual conference (SOT 2012)

San Francisco, CA

ToxStrategies’ scientists will be presenting short papers across mulitple sessions at the Society of Toxicology’s 51st Annual Meeting, from March 11-15, 2012, in San Francisco, CA. We are also excited to announce that ToxStrategies will be exhibiting at the ToxExpo. Please visit us in Booth #938 to learn more about our services and meet members of our staff. Click here for a complete list of our SOT 2012 presentations.

ToxStrategies welcomes Dr. Candace Doepker

Cincinnati Area, Ohio

We are pleased to announce that Dr. Candace Doepker has joined ToxStrategies, Inc., as the Food & Product Safety Practice Leader, and will be based in the Cincinnati, Ohio area. She was trained in the field of cytogenetic toxicology and has 16 years experience providing toxicological and scientific issues management support for many different multi-billion dollar food, health, beauty and oral care brands. Relevant to the food industry, Dr. Doepker has spent the last 6 years helping to ensure consumer safety, worker safety and general product stewardship in all of the following categories: coffee, snack foods, jams, jellies, baking mixes, juices, peanut butter, flavors and oils. Recently, she has developed a strong working knowledge of the Food Safety Modernization Act and is experienced in facilitating discussions with multi-disciplinary teams to prepare for its implementation. Additionally, she has helped to evaluate risk and guide the strategic direction of companies involved with topics such as actives in drug products, caffeine, Proposition 65 regulations, heat formed toxicants, nuisance dusts, workplace allergens and carbon monoxide. In all of these topic areas she gained significant experience in taking complex technical documents and issues and simplifying them in easy to understand language.

Dr. Doepker is recognized in the food industry for her strong working knowledge of diacetyl and workplace flavor safety. Dr. Doepker has served multiple years as the Chairwoman of the Caffeine and Food Ingredients committee at the International Food Information Council, as well as serving on the Council’s Board of Directors. She has been on the Scientific Advisory Board of the National Coffee Association for 5 years and has been an active member of both the Grocery Manufacturers Association and International Life Science Institute’s science and regulatory committees.

To read more about Dr. Doepker, or to obtain her new contact information, please click here.

 

ToxStrategies welcomes Gregory Brorby to the San Francisco Bay Area office

San Francisco Bay Area, California

We are pleased to announce that Mr. Gregory P. Brorby has joined ToxStrategies, Inc., as a Senior Managing Scientist. Mr. Brorby will be based in the San Francisco Bay Area, and greatly enhances our exposure assessment capabilities. He is a board-certified toxicologist with more than 25 years of experience in the fields of human health risk assessment, exposure simulation and dose reconstruction, and toxicology. Mr. Brorby has directed or participated in studies to estimate exposure to chemicals such as lead and phthalates from use of consumer products, particularly with regard to potential exposure via incidental hand-to-mouth contact, to assess compliance with CPSC, FDA, and California Proposition 65 requirements. He has also directed or participated in studies to reconstruct historic exposures to chemicals, including asbestos, in occupational settings. Mr. Brorby also conducts independent review of risk assessment-related work performed by others, and has significant experience communicating complicated technical information to a non-technical audience.

To read more about Mr. Brorby, or to obtain his new contact information, please click here.

ToxStrategies scientists to present at upcoming international dioxin symposium in Brussels, Belgium

Brussels, Belgium

ToxStrategies scientists will travel to Brussels, Belgium, this summer to present several short papers at the 31st International Symposium on Halogenated Persistent Organic Pollutants – Dioxin 2011.

Diliberto, J.J., Sirinek, L., Burkhalter, B., Wikoff, D.S.Hixon, G., Becker, J., Patterson, D.G., Turner, W., Tachovsky, J.A., Birnbaum, L.S., Haws, L.C. Endometriosis in a cohort of women living in the Kanawha River Valley in West Virginia: Blood levels of non-dioxin-like PCBs and relationship with BMI and age.

Haws, L.C., DeVito, M.J., Walker, N.J., Harris, M.A.Tachovsky, J.A., Birnbaum, L.S., Farland, W.H., Wikoff, D.S.Development of a consensus-based weighting framework for evaluating estimates of relative potency for dioxin-like compounds that includes consideration of data from human cells.

Haws, L.C.Fitzgerald, L., Burkhalter, B., Harris, M.Wikoff, D.S. Assessment of the US EPA’s proposed toxicological values for TCDD for regulation of dioxin-like compounds in foods: bridging the science divide in a global market.

Rowlands, J.C., Urban, J.Wikoff, D.S., Budinsky, R. The presence and estimated functional effect of single nucleotide polymorphisms at the AIP, ARNT, HSP90AA1, AND HSP90AB1 loci in the human population.

Thomas, R.S., Rowlands, J.C., Budinsky, R.A., Thompson, C.M.Urban, J.D., Dombkowski, A. Genomic approaches for relative potency assessment.

Wikoff, D.S.Thompson, C., Walker, N., DeVito, M., Harris, M., Birnbaum, L. Haws, L. Derivation of relative potency estimates using benchmark dose modeling: a case study with TCDF.

For a list of previous conference presentations, please see our Abstracts and Presentations.

Dr. Laurie Haws invited to speak at University of Texas Air Quality conference

Austin, TX

ToxStrategies Principal Health Scientist, Dr, Laurie Haws was invited to speak at the Air Quality 2010 conference, hosted by the University of Texas School of Law, on November 19, 2010. Dr. Haws delivered her presentation titled “Biomonitoring – A Tool for Assessing Community Exposures to Air Toxics”, to an audience that included attorneys, state and federal government representatives, and other environmental professionals. The full-day program was designed to help attorneys understand and work effectively with TCEQ, as well as provide a foundation for understanding pending EPA air quality programs.

ToxStrategies scientists host a successful Dioxin 2010 conference in San Antonio, TX

San Antonio, TX

Three years of preparation and hard work came to a rewarding end this September, with the successful completion of Dioxin 2010. Conference chairs, Drs Laurie Haws and Daniele Staskal-Wikoff, are proud to have organized and hosted the 30th International Symposium on Halogenated Persistent Organic Pollutants – Dioxin 2010, which drew over 800 participants from 41 countries. One highlight of the robust scientific program at the conference was the grand finale on Friday, which was an exciting, interactive session on the international regulation of POPs, including discussions led by international experts on how to bridge the gaps between science and policy.

In addition to chairing the conference, several ToxStrategies scientists presented work and co-chaired sessions. For a full list of abstracts presented at the Dioxin 2010, please see our 2010 Abstracts and Presentations.

 

ToxStrategies welcomes Michael Carakostas to the St. Helena Island, South Carolina Office

St. Helena Island, South Carolina

Michael Carakostas, DVM, PhD, DACVP has joined ToxStrategies, Inc as a Senior Consultant. Dr right here. Carakostas will be based near Beaufort, SC and will lead our Food and Supplement Safety Practice. He is a board certified veterinary clinical pathologist with 25 years of industry experience at several Fortune Global 500 corporations. Dr. Carakostas has extensive experience in food ingredient safety assessment, functional ingredient development, GRAS evaluations, food regulatory affairs and the management of risk and communication issues related to food safety, crisis management and product claims. He is also a nationally recognized expert in the interpretation clinical laboratory data from pre-clinical safety assessment studies, and has placed and monitored a number of pre-clinical safety assessment studies including target animal safety studies for veterinary pharmaceuticals. Dr. Carakostas has published extensively on a wide variety of topics including clinical veterinary medicine, chemical toxicology, clinical pathology data interpretation, animal drug evaluation and food ingredient safety assessment.

To read more about Dr. Carakostas, or to obtain his new contact information, please click here.